Equity Research Farm Products

Should You Buy Bunge Global SA Stock in 2026?

By CirclFi Research Team · · Updated · 10/13 models active

According to the CirclFi Deep Alpha Valuation Engine, Bunge Global SA (BG) carries a solid Quality of Company rating of 6.8/10. Trading at $121.76, our multi-model framework evaluates whether the company's financial profile offers a favorable risk-reward setup.

The short answer: 3 of 10 CirclFi valuation models project upside for Bunge Global SA (BG) at $121.76 — the model consensus leans bearish, with a Quality Score of 6.8/10 and Value-Trap risk of 44/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 7 of 10 models suggest overvaluation — majority bearish
  • Quality Score: 6.8/10 — Moderate — mixed signals
  • Value Trap Risk: 44/100 — Elevated — exercise caution
  • Fair Value Range: $35.28 – $252.91 (617% spread)

Bullish Models

3 / 10

Bearish Models

7 / 10

Quality Score

6.8 /10

Moderate — mixed signals

Value Trap Risk

44 /100
Elevated

Elevated — exercise caution

Model Consensus

10 /13
Active Models

Avg. confidence: 49%

What Is the Investment Case for Bunge Global SA (BG) in 2026?

What Is the Bull Case vs the Bear Case for Bunge Global SA (BG)?

Bull case versus bear case for Bunge Global SA (BG) at $121.76, derived from 10 active CirclFi valuation models on 2026-09-15.
Bull case — $252.91 target (+107.7%) Bear case — $35.28 target (-71.0%)
According to the CirclFi Deep Alpha Valuation Engine, the Regime Cross-Sectional model targets a fair value of $252.91 (+107.7%), anchoring the bull case with a methodology that provides a differentiated analytical lens. According to the CirclFi Value Trap algorithm, the stock shows moderate caution signals, meaning investors should verify that apparent undervaluation isn't masking declining business quality.
According to the CirclFi Deep Alpha Valuation Engine, the EROIC Spread model sees the stock as overvalued with a fair value of $35.28 (-71.0%), suggesting that the market price embeds overly optimistic growth assumptions.
According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +178.7% spread between the most bullish and bearish models, signaling elevated analytical uncertainty.

How Does BG Compare to Its Farm Products Peers?

AGRZ Agroz Inc.
6.9
LND BrasilAgro - Companh
6.6
ADM Archer-Daniels-Midla
7.5
TULP Bloomia Holdings, In
6.6
TSN Tyson Foods, Inc.
7.6
LMNR Limoneira Company
6.3
LOCL Local Bounti Corpora
6.1
SDOT Sadot Group Inc.
3.6

Valuation data pages: AGRZ · LND · ADM · TULP · TSN · LMNR · LOCL · SDOT · VITL · CALM · VFF

Which Other Stocks Score Like BG on Quality?

Closest companies to BG’s Quality of Company score of 6.8/10, across all industries.

Why Do CirclFi’s 10 Models Disagree on BG?

Spread

617%

Fair Value Range

$35.28 – $252.91

A 617% spread signals high uncertainty. The investment outcome depends heavily on which scenario plays out.

Most Bullish

Regime Cross

$252.91 (+107.7%)

Most Bearish

EROIC

$35.28 (-71.0%)

What Are the Biggest Risks of Buying BG Stock?

Value Trap Warning

VT score 44/100 — apparent discount may mask decay.

Model Disagreement

617% spread signals high variance in projections.

Bearish Consensus

7/10 models suggest overvaluation.

Macro/Sector Risk

Farm Products headwinds could affect earnings trajectory.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View BG Data Page →

So Is Bunge Global SA (BG) Worth Buying in 2026?

Caution dominates our read on Bunge Global SA at $121.76. 7 of 10 models see limited upside or outright downside, with the median fair value at $98.98 (-18.7%). Quality at 6.8/10 provides some fundamental cushion. Current holders should re-evaluate their thesis; new buyers should demand a wider margin of safety.

These are quantitative model outputs, not investment recommendations. Bunge Global SA's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

What Else Do Investors Ask About BG Stock?

Should I buy BG stock right now?

Based on CirclFi's multi-model analysis, 3 of 10 models see upside for BG at $121.76. The models are divided, which means the investment case depends heavily on your assumptions about Bunge Global SA's future. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in Bunge Global SA?

Key risks include: an elevated Value Trap score of 44/100, suggesting apparent undervaluation may mask deteriorating fundamentals; wide model disagreement (617% spread), signaling high uncertainty; general market and sector-specific risks affecting Farm Products companies. Always diversify and consult a financial advisor.

How does BG compare to its competitors?

Among Farm Products peers, BG holds a Quality Score of 6.8/10. Comparable companies include AGRZ (QOC 6.9), LND (QOC 6.6), ADM (QOC 7.5). The relative ranking helps investors identify whether BG offers better fundamental quality than alternatives in the same sector.

Is BG a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. BG's Quality Score of 6.8/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.

What price should I buy BG at?

CirclFi does not provide target buy prices or price alerts. However, our 10 active models produce fair value estimates ranging from $35.28 to $252.91. At $121.76, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for BG.

View BG Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →